Health & bio

Idvynso (doravirine-islatravir) HIV therapy expected April 21

BioPharma Dive and FDA tracker peg late-April approval for doravirine combo. Chronic infection line expands.

Primary sources · 1
FDA Tracker
← View the full 2026-04-07 (Tue) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →